Mga Batayang Estadistika
| LEI | 549300NQQCEQ46YHZ591 |
| CIK | 1179929 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Molina Healthcare, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission F |
|
| August 12, 2025 |
Exhibit 10.1 FOURTH AMENDMENT to CREDIT AGREEMENT dated as of August 12, 2025 among MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC., BARCLAYS BANK PLC, BOFA SECURITIES, N.A., DEUTSCHE BANK SECURITIES INC., GOLDMAN SACHS LENDER PARTNERS LLC, JPMORGAN CHASE BANK N.A., |
|
| July 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| July 23, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fil |
|
| July 23, 2025 |
Molina Healthcare Reports Second Quarter 2025 Financial Results Revises Full Year 2025 Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2025 Financial Results Revises Full Year 2025 Guidance Long Beach, Calif, July 23, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2025 GA |
|
| July 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission File |
|
| July 7, 2025 |
Exhibit 99.1 News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance Long Beach, Calif., July 7, 2025 – Molina Healthcare, Inc. (NYSE: MOH) today |
|
| May 1, 2025 |
As filed with the Securities and Exchange Commission on May 1, 2025 As filed with the Securities and Exchange Commission on May 1, 2025 Registration No. |
|
| May 1, 2025 |
Calculation of Filing Fee Tables S-8 MOLINA HEALTHCARE, INC. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common stock, $0.001 par value per share 457(a) 2,811,729 $ 308.67 $ 867,896,390.43 0.0001531 $ 132,874.94 To |
|
| May 1, 2025 |
Molina Healthcare, Inc. 2025 Equity Incentive Plan Molina Healthcare, Inc. 2025 Equity Incentive Plan Effective as of April 30, 2025 1.ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. Molina Healthcare, Inc. previously adopted the Molina Healthcare, Inc. 2019 Equity Incentive Plan (the “2019 Plan”). The 2019 Plan is hereby amended, restated, and merged into the Molina Healthcare, Inc. 2025 Equity Incentive Plan (the “Plan”) effective as |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0 |
|
| April 24, 2025 |
Molina Healthcare, Inc. 2019 Equity Incentive Plan (As Amended 2025) 1 #695970v2 Molina Healthcare, Inc. 2019 Equity Incentive Plan Effective as of May 8, 2019 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. Molina Healthcare, Inc. previously adopted the Molina Healthcare, Inc. 2011 Equity Incentive Plan (the “2011 Plan”), most recently amended and restated as of January 1, 2017. The 2011 Plan is hereby amended, restated, and merged into the Molina H |
|
| April 23, 2025 |
Molina Healthcare Reports First Quarter 2025 Financial Results Reaffirms Full Year 2025 Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2025 Financial Results Reaffirms Full Year 2025 Guidance Long Beach, Calif, April 23, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2025 G |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 18, 2025 |
Molina Healthcare Wins Illinois Contract to Provide a Dual Eligible Special Needs Plan Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Wins Illinois Contract to Provide a Dual Eligible Special Needs Plan LONG BEACH, Calif., Mar. 18, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that th |
|
| March 18, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ú Preliminary Proxy Statement ú Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| February 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| February 21, 2025 |
Exhibit 10.1 THIRD AMENDMENT to CREDIT AGREEMENT dated as of February 19, 2025 among MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC., as Lead Arranger and Bookrunner 1 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT, dated as of February |
|
| February 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-31719 MOLINA HEALTHCARE |
|
| February 11, 2025 |
EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware Central Health Plan of California, Inc. California ConnectiCare Holding Company, Inc.** Connecticut ConnectiCare Capital, LLC++++++** Connecticut ConnectiCare, Inc.+++++++** Connecticut ConnectiCare Insurance Company, Inc.+++++++** Connecticut ConnectiCare Benefits, Inc.++++++++** Connecticut MHAZ |
|
| February 11, 2025 |
Description of Registrant’s Securities DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The Common Stock of Molina Healthcare, Inc. |
|
| February 11, 2025 |
Molina Healthcare, Inc. 2019 Equity Incentive Plan {00404251;1} 1 Molina Healthcare, Inc. 2019 Equity Incentive Plan Effective as of May 8, 2019 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. Molina Healthcare, Inc. previously adopted the Molina Healthcare, Inc. 2011 Equity Incentive Plan (the “2011 Plan”), most recently amended and restated as of January 1, 2017. The 2011 Plan is hereby amended, restated, and merged into the Molin |
|
| February 5, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| February 5, 2025 |
News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2024 Financial Results Introduces Full Year 2025 Revenue and Earnings Guidance Long Beach, Calif, February 5, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company |
|
| February 3, 2025 |
Molina Healthcare Announces the Closing of its Acquisition of ConnectiCare Exhibit 99.1 News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces the Closing of its Acquisition of ConnectiCare Long Beach, Calif., Feb. 3, 2025 – Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of ConnectiCare Holding |
|
| February 3, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| December 16, 2024 |
Molina Healthcare Awarded Contracts to Serve Dual Eligible Populations in Michigan and Idaho Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Awarded Contracts to Serve Dual Eligible Populations in Michigan and Idaho LONG BEACH, Calif., Dec. 16, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today t |
|
| December 16, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| November 18, 2024 |
Exhibit 4.1 MOLINA HEALTHCARE, INC. $750,000,000 6.250% Senior Notes due 2033 INDENTURE Dated as of November 18, 2024 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 14 Section 1.03 Incorporation by Reference of Trust Indenture Act 15 Section 1.04 Rules o |
|
| November 18, 2024 |
Molina Healthcare Announces Closing of Offering of $750 Million of 6.250% Senior Notes Due 2033 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Closing of Offering of $750 Million of 6.250% Senior Notes Due 2033 Long Beach, Calif., November 18, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the cl |
|
| November 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi |
|
| November 13, 2024 |
Molina Healthcare Announces Proposed Offering of $500 Million of Senior Notes Due 2033 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Proposed Offering of $500 Million of Senior Notes Due 2033 Long Beach, Calif., November 13, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it intends |
|
| November 13, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi |
|
| November 13, 2024 |
Molina Healthcare Announces Pricing of $750 Million of 6.250% Senior Notes Due 2033 EX-99.1 2 ex747620.htm EXHIBIT 99.1 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Pricing of $750 Million of 6.250% Senior Notes Due 2033 Long Beach, Calif., November 13, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company” |
|
| November 13, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| November 12, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| November 8, 2024 |
JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Molina Healthcare, Inc. |
|
| November 8, 2024 |
Molina Healthcare, Inc. 2024 Investor Day Presentation, dated November 8, 2024. Exhibit 99.1 |
|
| November 8, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| October 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 23, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| October 23, 2024 |
News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2024 Financial Results Reaffirms Full Year 2024 Earnings Guidance Long Beach, Calif, October 23, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third qua |
|
| October 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2024 (October 16, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| October 17, 2024 |
Performance Stock Unit Agreement, dated as of October 16, 2024. Exhibit 10.1 MOLINA HEALTHCARE, INC. 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AWARD AGREEMENT THIS PERFORMANCE STOCK UNIT AWARD AGREEMENT (together with the Terms (as defined below) and Exhibit A hereto, this “Agreement”) dated October 16, 2024, by and between MOLINA HEALTHCARE, INC., a Delaware corporation (the “Corporation”), and Mark L. Keim (the “Participant”), evidences the award of |
|
| October 16, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| October 16, 2024 |
Molina Healthcare Wins Michigan Contract to Provide a New Dual Eligible Benefit Program Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Wins Michigan Contract to Provide a New Dual Eligible Benefit Program LONG BEACH, Calif., Oct. 16, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that t |
|
| September 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2024 (September 20, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of inco |
|
| September 23, 2024 |
Exhibit 10.1 SECOND AMENDMENT to CREDIT AGREEMENT dated as of September 20, 2024 among MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC. BARCLAYS BANK PLC BOFA SECURITIES, INC. DEUTSCHE BANK SECURITIES INC. GOLDMAN SACHS LENDING PARTNERS LLC JPMORGAN CHASE BANK, N.A. |
|
| August 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2024 (August 19, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat |
|
| August 20, 2024 |
Performance Stock Unit Agreement, dated as of August 19, 2024. Exhibit 10.2 MOLINA HEALTHCARE, INC. 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AWARD AGREEMENT THIS PERFORMANCE STOCK UNIT AWARD AGREEMENT (together with the Terms (as defined below) and Exhibit A hereto, this “Agreement”) dated August 19, 2024, by and between MOLINA HEALTHCARE, INC., a Delaware corporation (the “Corporation”), and Joseph M. Zubretsky (the “Participant”), evidences the awa |
|
| August 20, 2024 |
Exhibit 10.1 AMENDMENT OF EMPLOYMENT AGREEMENT This Amendment of Employment Agreement is entered into as of August 19, 2024, by and between Joseph M. Zubretsky (the “Executive”) and Molina Healthcare, Inc. (the “Employer”). WHEREAS, the parties entered into that certain Amended and Restated Employment Agreement dated as of September 8, 2021, as amended on February 16, 2022 (the “Agreement”); and W |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| July 24, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fil |
|
| July 24, 2024 |
News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2024 Financial Results Reaffirms Full Year 2024 Earnings Guidance Long Beach, Calif, July 24, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quar |
|
| May 3, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission File |
|
| April 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0 |
|
| April 24, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 24, 2024 |
Molina Healthcare Reports First Quarter 2024 Financial Results Reaffirms Full Year 2024 Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2024 Financial Results Reaffirms Full Year 2024 Guidance Long Beach, Calif, April 24, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2024 G |
|
| April 11, 2024 |
Molina Healthcare Wins Michigan Medicaid Contract Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Wins Michigan Medicaid Contract LONG BEACH, Calif., Apr. 11, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that the Michigan Department of Health and H |
|
| April 11, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2024 (April 8, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation |
|
| March 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ú Preliminary Proxy Statement ú Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| February 29, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| February 29, 2024 |
Molina Healthcare Provides Update on the Virginia Cardinal Care Managed Care Contract Exhibit 99.1 News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Provides Update on the Virginia Cardinal Care Managed Care Contract LONG BEACH, Calif., Feb. 29, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-31719 MOLINA HEALTHCARE |
|
| February 13, 2024 |
Molina Healthcare, Inc. 2019 Equity Incentive Plan {00404251;1} 1 Molina Healthcare, Inc. 2019 Equity Incentive Plan Effective as of May 8, 2019 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. Molina Healthcare, Inc. previously adopted the Molina Healthcare, Inc. 2011 Equity Incentive Plan (the “2011 Plan”), most recently amended and restated as of January 1, 2017. The 2011 Plan is hereby amended, restated, and merged into the Molin |
|
| February 13, 2024 |
Certificate of Amendment to Certificate of Incorporation Jeffrey mBulloa,secmtary astate AUTHEN TION: 0404163 DATE: 05-02-13 Delaware PAGE I The First State I, JEFFREY W. |
|
| February 13, 2024 |
Certificate of Amendment to Certificate of Incorporation Delaware The First State Page 1 3551135 8100 Authentication: 202800933 SR# 20193729983 Date: 05-10-19 You may verify this certificate online at corp. |
|
| February 13, 2024 |
MOH / Molina Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01476-molinahealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Molina Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to d |
|
| February 13, 2024 |
2019 Employee Stock Purchase Plan Table of Contents Appendix C - 1 MOLINA HEALTHCARE, INC. 2019 EMPLOYEE STOCK PURCHASE PLAN EFFECTIVE MAY 8, 2019 1. Establishment of Plan. Molina Healthcare, Inc., a Delaware corporation (the “Company”), previously adopted the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan (the “2011 Plan”), most recently amended as of July 26, 2016, to grant options to purchase shares of the Company’s |
|
| February 13, 2024 |
EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware Central Health Plan of California, Inc. ++++++ California MHAZ, Inc.* Arizona Molina Healthcare Data Center, LLC New Mexico Molina Healthcare of Arizona, Inc. Arizona Molina Healthcare of California California Molina Healthcare of Florida, Inc. Florida Molina Healthcare of Georgia, Inc.* Georgia M |
|
| February 13, 2024 |
Molina Healthcare, Inc. Policy for Recovery of Erroneously Awarded Compensation #606562v4 MOLINA HEALTHCARE, INC. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Molina Healthcare, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined in the text of this Policy are defined in Section 11. Except |
|
| February 9, 2024 |
MOH / Molina Healthcare, Inc. / Capital World Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 8, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MOLINA HEALTHCARE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| February 7, 2024 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-549-4100 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2023 Financial Results Introduces Full Year 2024 Revenue and Earnings Guidance Long Beach, Calif, February 7, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “C |
|
| January 2, 2024 |
Exhibit 99.1 Molina Healthcare Announces the Closing of its Acquisition of Bright Healthcare’s California Medicare Business LONG BEACH, Calif.-(BUSINESS WIRE)-January 2, 2024-Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of Bright Healthcare’s California Medicare business closed effective as of January 1, 2024. At closing, Bright Healthcare’s California Medicare business |
|
| January 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 2, 2024 (January 2, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| December 26, 2023 |
Amended and Restated Bylaws of Molina Healthcare, Inc. molinahealthcare-amended AMENDED AND RESTATED BYLAWS OF MOLINA HEALTHCARE, INC. a Delaware corporation (as Amended and Restated Effective December 22, 2023) i TABLE OF CONTENTS Page ARTICLE I OFFICES .....................................................................................................................1 Section 1.1 Registered Office.................................................... |
|
| December 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2023 (December 22, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp |
|
| December 18, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2023 (December 18, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco |
|
| December 18, 2023 |
Molina Healthcare Amends Terms for Acquisition of Bright HealthCare’s California Medicare Business Exhibit 99.1 Molina Healthcare Amends Terms for Acquisition of Bright HealthCare’s California Medicare Business Expected closing on or about January 1, 2024 LONG BEACH, Calif.-(BUSINESS WIRE)-December 18, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that on December 13, 2023, the Company amended its purchase agreement for the acquisition of Bright HealthCare |
|
| October 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 26, 2023 |
First Amendment to Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2022) AMENDMENT NO. ONE TO THE MOLINA HEALTHCARE, INC. AMENDED AND RESTATED DEFERRED COMPENSATION PLAN (2022) Section 7 of the Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2022) effective for amounts earned and deferred on or after January 1, 2022 (the “Plan”) allows Molina Healthcare, Inc. (the “Company”) to amend the terms of the Plan, at any time by resolution of the Plan |
|
| October 25, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2023 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission |
|
| October 25, 2023 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-549-4100 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2023 Financial Results Affirms Full Year 2023 Earnings Guidance Long Beach, Calif, October 25, 2023 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2023 (September 27, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incor |
|
| September 5, 2023 |
Molina Healthcare Announces the Closing of its Acquisition of My Choice Wisconsin Exhibit 99.1 Molina Healthcare Announces the Closing of its Acquisition of My Choice Wisconsin LONG BEACH, Calif.-(BUSINESS WIRE)-September 5, 2023-Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of My Choice Wisconsin (“MCW”) closed on September 1, 2023. As of June 30, 2023, MCW served over 44,000 members. About Molina Healthcare Molina Healthcare, Inc., a FORTUNE 500 com |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 (September 1, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco |
|
| August 14, 2023 |
Molina Healthcare of New Mexico Receives Notification of Intent to Award New Medicaid Contract Exhibit 99.1 Molina Healthcare of New Mexico Receives Notification of Intent to Award New Medicaid Contract LONG BEACH, Calif.-(BUSINESS WIRE)-August 14, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) confirmed that the New Mexico Human Services Department (HSD) has announced its intention to award a Medicaid managed care contract to Molina’s New Mexico health plan, Molina He |
|
| August 14, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 (August 14, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2023 (May 3, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporatio |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| July 26, 2023 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-549-4100 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2023 Financial Results Increases Full-Year 2023 Earnings Guidance Long Beach, Calif, July 26, 2023 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported secon |
|
| July 26, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2023 (July 26, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2023 (June 30, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporatio |
|
| June 30, 2023 |
Molina Healthcare to Acquire Bright HealthCare’s California Medicare Business Exhibit 99.1 Molina Healthcare to Acquire Bright HealthCare’s California Medicare Business Transaction expands Molina’s Medicare presence in California and is expected to add $1.00 per share to new store embedded earnings1 LONG BEACH, Calif.-(BUSINESS WIRE)-June 30, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that it has entered into a definitive agreement |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 (May 15, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| May 16, 2023 |
Molina Healthcare Announces Promotions of Two Senior Executives Exhibit 99.1 Molina Healthcare Announces Promotions of Two Senior Executives LONG BEACH, Calif.-(BUSINESS WIRE)-May 16, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) today announced that Jim Woys and Mark Keim have each been promoted to the position of senior executive vice president, effective May 15th. With this promotion, Woys also assumes the role of chief operating officer. Keim will co |
|
| May 16, 2023 |
Exhibit 99.2 Investor Day 2023Sustaining Profitable Growth:The Next Wave May 15, 2023 Sustaining Profitable Growth: The Next Wave Topic Speaker Welcome and Introduction Joe Krocheski Sustaining Profitable Growth Joe Zubretsky Compelling Financial Profile Mark Keim Executive Q&A Joe Zubretsky Mark Keim Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2023 (May 3, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Co |
|
| April 27, 2023 |
exhibit101firstamendmen 1312454.1 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of April 26, 2023 (this “Amendment”), is entered into between Molina Healthcare, Inc., a Delaware corporation (the “Borrower”), and Truist Bank, in its capacity as Administrative Agent (the “Administrative Agent”), effective as of the Effective Time (as defined below). Capitaliz |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0 |
|
| April 26, 2023 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2023 Financial Results Increases Full-Year 2023 Earnings Guidance Long Beach, Calif, April 26, 2023 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2023 (April 26, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporatio |
|
| March 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ú Preliminary Proxy Statement ú Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2023 (March 6, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporatio |
|
| March 6, 2023 |
Molina Healthcare of Indiana Recommended for MLTSS Award Exhibit 99.1 Molina Healthcare of Indiana Recommended for MLTSS Award LONG BEACH, Calif.-(BUSINESS WIRE)-March 6, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) today announced that the Indiana Department of Administration has recommended that contract negotiations begin with Molina’s Indiana health plan, Molina Healthcare of Indiana, Inc. Under the proposed contract with the Indiana Family a |
|
| February 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant a |
|
| February 13, 2023 |
EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware MHAZ, Inc.* Arizona Molina Healthcare Data Center, LLC New Mexico Molina Healthcare of Arizona, Inc. Arizona Molina Healthcare of California California Molina Healthcare of Florida, Inc. Florida Molina Healthcare of Georgia, Inc.* Georgia Molina Healthcare of Illinois, Inc. Illinois Molina Healthc |
|
| February 13, 2023 |
MOH / Molina Healthcare, Inc. / Capital World Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 9, 2023 |
MOH / Molina Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01443-molinahealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Molina Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to d |
|
| February 8, 2023 |
EX-99.1 2 moh4q22er.htm EX-99.1 News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2022 Financial Results Introduces Full-Year 2023 Revenue and Earnings Guidance Long Beach, Calif, February 8, 2023 – Molina Heal |
|
| February 8, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2023 (February 8, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| February 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* MOLINA HEALTHCARE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| January 4, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2023 (January 3, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat |
|
| January 4, 2023 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Projects its California Medicaid Revenue will Double Under Revised Medi-Cal Contract Awards LONG BEACH, Calif., January 3, 2023 ? Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) confirmed today tha |
|
| December 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2022 (December 30, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco |
|
| December 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2022 (December 28, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco |
|
| October 27, 2022 |
Pursuant to Item 601(b)(10) of Regulation S-K, portions of this exhibit have been excluded because the information is not material and is the type that the registrant treats as confidential. |
|
| October 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 26, 2022 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance Long Beach, Calif, October 26, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today |
|
| October 26, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2022 (October 26, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| October 3, 2022 |
Exhibit 99.1 Molina Healthcare Announces the Closing of its Acquisition of AgeWell New York?s Managed Long Term Care Plan LONG BEACH, Calif.-(BUSINESS WIRE)-October 3, 2022-Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of AgeWell New York?s Medicaid Managed Long Term Care (MLTC) business closed on October 1, 2022. As of September 30, 2022, AgeWell New York?s MLTC busines |
|
| October 3, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2022 (October 1, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| September 26, 2022 |
Molina Healthcare Selected For Nebraska Medicaid Managed Care Program Exhibit 99.1 Molina Healthcare Selected For Nebraska Medicaid Managed Care Program LONG BEACH, Calif.-(BUSINESS WIRE)-September 26, 2022-Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) today announced that its health plan subsidiary, Molina Healthcare of Nebraska, has been selected by the Nebraska Department of Health and Human Services (DHHS) to provide health care services to Nebraskans under the |
|
| September 26, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2022 (September 23, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of in |
|
| August 31, 2022 |
Molina Healthcare Wins Iowa Medicaid Contract Exhibit 99.1 Molina Healthcare Wins Iowa Medicaid Contract LONG BEACH, Calif.-(BUSINESS WIRE)-August 31, 2022-Molina Healthcare, Inc. (NYSE: MOH) (?Molina? or the ?Company?) confirmed that the Iowa Department of Health and Human Services (HHS) has announced its intent to award Molina?s Iowa health plan a Medicaid managed care contract pursuant to the Request for Proposal issued by HHS on February |
|
| August 31, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2022 (August 31, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| August 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2022 (August 25, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| August 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2022 (August 17, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat |
|
| August 10, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2022 (August 10, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat |
|
| August 10, 2022 |
Molina Healthcare Receives Notice of Intent to Award Mississippi Medicaid Contract NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Receives Notice of Intent to Award Mississippi Medicaid Contract LONG BEACH, Calif., Aug. 10, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) announced that its Mississippi health plan subsi |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| July 27, 2022 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance Long Beach, Calif, July 27, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today re |
|
| July 27, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2022 (July 27, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| July 13, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2022 (July 13, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporatio |
|
| July 13, 2022 |
Molina Healthcare to Acquire My Choice Wisconsin Exhibit 99.1 Molina Healthcare to Acquire My Choice Wisconsin Transaction Expands Molina?s Medicaid Managed Long-Term Care Presence into Wisconsin LONG BEACH, Calif.-(BUSINESS WIRE)-July 13, 2022-Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) announced today that it has entered into a definitive agreement to acquire substantially all the assets of My Choice Wisconsin (?MCW?). The purchase price fo |
|
| May 6, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2022 (May 4, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Co |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0 |
|
| April 27, 2022 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance Long Beach, Calif, April 27, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today re |
|
| April 27, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2022 (April 27, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporatio |
|
| April 8, 2022 |
MOH / Molina Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Molina Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: March 31, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ? |
|
| March 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| February 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2022 (February 16, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp |
|
| February 16, 2022 |
Exhibit 10.1 AMENDMENT OF EMPLOYMENT AGREEMENT This Amendment of Employment Agreement is entered into as of February 16, 2022, by and between Joseph M. Zubretsky (the ?Executive?) and Molina Healthcare, Inc. (the ?Employer?). WHEREAS, the parties entered into that certain Amended and Restated Employment Agreement dated as of September 8, 2021 (the ?Agreement?); and WHEREAS, the parties desire to a |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant a |
|
| February 14, 2022 |
Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2022) MOLINA HEALTHCARE, INC. AMENDED AND RESTATED DEFERRED COMPENSATION PLAN (2022) This Deferred Compensation Plan (the ?Plan?) is amended and restated effective for amounts earned and deferred on or after January 1, 2022 (the ?Restatement?), by MOLINA HEALTHCARE, INC., a Delaware corporation (the ?Company?) with reference to the following: A. The Company originally established a Deferred Compensation |
|
| February 14, 2022 |
EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware MHAZ, Inc.* Arizona Molina Healthcare Data Center, LLC New Mexico Molina Healthcare of Arizona, Inc. Arizona Molina Healthcare of California California Molina Healthcare of Florida, Inc. Florida Molina Healthcare of Georgia, Inc.* Georgia Molina Healthcare of Illinois, Inc. Illinois Molina Healthc |
|
| February 11, 2022 |
MOH / Molina Healthcare, Inc. / Capital World Investors - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th |
|
| February 10, 2022 |
MOH / Molina Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Molina Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 9, 2022 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2021 Financial Results Introduces Full Year 2022 Earnings Guidance Long Beach, Calif, February 9, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) tod |
|
| February 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2022 (February 9, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MOLINA HEALTHCARE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| November 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 (November 16, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp |
|
| November 16, 2021 |
Molina Healthcare Announces Closing of Offering of $750 Million of 3.875% Senior Notes Due 2032 NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Closing of Offering of $750 Million of 3.875% Senior Notes Due 2032 Long Beach, Calif., November 16, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today announced the closin |
|
| November 16, 2021 |
Molina Healthcare Announces Closing of Offering of $750 Million of 3.875% Senior Notes Due 2032 NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Closing of Offering of $750 Million of 3.875% Senior Notes Due 2032 Long Beach, Calif., November 16, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today announced the closin |
|
| November 16, 2021 |
US-DOCS\127593076.31203368.1 MOLINA HEALTHCARE, INC. $750,000,000 3.875% Senior Notes due 2032 INDENTURE Dated as of November 16, 2021 U.S. BANK NATIONAL ASSOCIATION as Trustee -i- US-DOCS\127593076.31203368.1 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE ............................................... 1 Section 1.01 Definitions. ...................................... |
|
| November 16, 2021 |
US-DOCS\127593076.31203368.1 MOLINA HEALTHCARE, INC. $750,000,000 3.875% Senior Notes due 2032 INDENTURE Dated as of November 16, 2021 U.S. BANK NATIONAL ASSOCIATION as Trustee -i- US-DOCS\127593076.31203368.1 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE ............................................... 1 Section 1.01 Definitions. ...................................... |
|
| November 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 (November 16, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp |
|
| November 2, 2021 |
Exhibit 1.1 PURCHASE AGREEMENT November 1, 2021 TRUIST Securities, Inc. As Representative of the Initial Purchasers c/o Truist Securities, Inc. 3333 Peachtree Road, 11th Floor Atlanta, GA 30326 Ladies and Gentlemen: Molina Healthcare, Inc., a Delaware corporation (the ?Company?), proposes to issue and sell to Truist Securities, Inc. (?Truist?) and the other several Initial Purchasers named in Sche |
|
| November 2, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2021 (November 1, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorp |
|
| November 2, 2021 |
Molina Healthcare Announces Pricing of $750 Million of Senior Notes Due 2032 Exhibit 99.1 Molina Healthcare Announces Pricing of $750 Million of Senior Notes Due 2032 LONG BEACH, Calif.-(BUSINESS WIRE)-November 1, 2021-Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today announced that it priced $750 million aggregate principal amount of its senior notes due 2032 (the ?Notes?) to be sold in a private offering to individuals reasonably believed to be ?qualified institu |
|
| November 1, 2021 |
Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2032 Exhibit 99.1 Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2032 LONG BEACH, Calif.-(BUSINESS WIRE)-November 1, 2021-Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today announced that it intends to privately offer, subject to market and other conditions, $750 million aggregate principal amount of senior notes due 2032 (the ?Notes?). The Company will make th |
|
| November 1, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2021 (November 1, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorp |
|
| October 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 27, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2021 (October 27, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| October 27, 2021 |
News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2021 Financial Results Reaffirms Full Year 2021 Earnings Guidance Long Beach, Calif, October 27, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today reported thi |
|
| October 25, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2021 (October 25, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| October 25, 2021 |
Molina Healthcare Announces the Closing of its Acquisition of Affinity Health Plan NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces the Closing of its Acquisition of Affinity Health Plan Long Beach, Calif., Oct. 25, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) announced today that its acquisition of Affinity |
|
| October 7, 2021 |
NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare to Acquire Certain Assets of AgeWell New York Deal Grows Molina?s Medicaid Managed Long Term Care Presence in New York, Maintains Continuity of Care for Members and Stability for State Partners LO |
|
| October 7, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2021 (October 7, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat |
|
| September 17, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2021 (September 17, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of inco |
|
| September 17, 2021 |
Investor Day 2021 Sustaining Profitable Growth September 17, 2021 2 Sustaining Profitable Growth Topic Speaker 8:30am Welcome and Logistics ? Ron Kurtz 8:35am Sustaining Profitable Growth ? Joe Zubretsky 9:30am Compelling Financial Profile ? Mark Keim 10:00am ? 10:45am Executive Q&A ? Joe Zubretsky ? Mark Keim 3 Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Ref |
|
| September 9, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2021 (September 8, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco |
|
| September 9, 2021 |
Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (this ?Agreement?) is made as of September 8, 2021, between Joseph M. Zubretsky (the ?Executive?) and Molina Healthcare, Inc. (the ?Employer?). RECITALS WHEREAS, the Employer and the Executive are parties to an Employment Agreement, dated October 9, 2017 (the ?Original Agreement?), pursuant to whi |
|
| September 9, 2021 |
Molina Healthcare Signs CEO Joe Zubretsky to New Employment Agreement Exhibit 99.1 Molina Healthcare Signs CEO Joe Zubretsky to New Employment Agreement LONG BEACH, Calif.-(BUSINESS WIRE)-September 9, 2021-Molina Healthcare, Inc. (NYSE: MOH) announced today that it has entered into an amended and restated employment agreement with its President and CEO, Joe Zubretsky. The Chairman of Molina?s Board of Directors, Dale Wolf, said, ?During his nearly four-year tenure, |
|
| August 17, 2021 |
Molina Healthcare Awarded Nevada Medicaid Contract News Release Investor Contact: Ronald Kurtz, [email protected], 562-912-6820 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Awarded Nevada Medicaid Contract LAS VEGAS, Aug. 17, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) today announced its Nevada health plan subsidiary was awarded a Medicaid managed care contract fr |
|
| August 17, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 (August 17, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat |
|
| July 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| July 28, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2021 (July 28, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| July 28, 2021 |
News Release Investor Contact: Julie Trudell, [email protected], 562-912-6720 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2021 Financial Results Increases Full Year 2021 Earnings Guidance Long Beach, Calif, July 28, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today reported second quar |
|
| May 11, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2021 (May 6, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (C |
|
| April 29, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0 |
|
| April 28, 2021 |
News Release Investor Contact: Julie Trudell, [email protected], 562-912-6720 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2021 Financial Results Increases Full Year 2021 Earnings Guidance Long Beach, Calif, April 28, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today reported first quart |
|
| April 28, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2021 (April 28, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporatio |
|
| April 13, 2021 |
Molina Healthcare Wins Ohio Medicaid Contracts Exhibit 99.1 Molina Healthcare Wins Ohio Medicaid Contracts LONG BEACH, Calif.-(BUSINESS WIRE)-April 13, 2021-Molina Healthcare, Inc. (NYSE: MOH) today announced that its Ohio health plan subsidiary has been selected as an awardee in all three regions across the state pursuant to the Medicaid managed care RFA issued on September 30, 2020, by the Ohio Department of Medicaid (ODM). The new contract |
|
| April 13, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2021 (April 13, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporat |
|
| March 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| March 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| February 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2020 (February 17, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other ju |
|
| February 18, 2021 |
WAIVER AND RELEASE AGREEMENT This Waiver and Release Agreement (?Agreement? and/or ?Release?) is made and entered into as of this 22nd day of December, 2020 (the ?Effective Date?), by and between Thomas L. |
|
| February 16, 2021 |
MOLINA HEALTHCARE, INC. SECOND AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE PLAN (As Amended and Restated as of February 9, 2021) I. INTRODUCTION Molina Healthcare, Inc. considers the maintenance of a sound management to be essential to protecting and enhancing the best interests of the Company and its stockholders. Thus, the Company recognizes that the possibility of a Change in Control may e |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| February 16, 2021 |
DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The Common Stock of Molina Healthcare, Inc. |
|
| February 16, 2021 |
AMENDMENT NO. TWO TO THE MOLINA HEALTHCARE, INC. AMENDED AND RESTATED DEFERRED COMPENSATION PLAN (2018) Section 7 of the Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2018) effective for amounts earned and deferred on or after January 1, 2018 (the ?Plan?) allows Molina Healthcare, Inc. (the ?Company?) to amend the terms of the Plan, at any time by resolution of the Plan |
|
| February 16, 2021 |
EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware Molina Healthcare Data Center, LLC New Mexico Molina Healthcare of Arizona, Inc.* Arizona Molina Healthcare of California California Molina Healthcare of Florida, Inc. Florida Molina Healthcare of Georgia, Inc.* Georgia Molina Healthcare of Illinois, Inc. Illinois Molina Healthcare of Kentucky, In |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant a |
|
| February 10, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2021 (February 10, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp |
|
| February 10, 2021 |
moh4q20supplementfinal 4Q20 Earnings Supplement February 10, 2021 This 4Q20 Earnings Supplement should be read together and in conjunction with the Company’s earnings release dated February 10, 2021. |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Molina Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 10, 2021 |
News Release Investor Contact: Julie Trudell, [email protected], 562-912-6720 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2020 Financial Results Introduces Full Year 2021 Earnings Guidance Long Beach, Calif, February 10, 2021 – Molina Healthcare, Inc. (NYSE: MOH) today reported net incom |
|
| January 14, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2021 (January 14, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorp |
|
| January 14, 2021 |
Exhibit 99.1 Molina Healthcare, Inc.JP Morgan Healthcare Conference Joe Zubretsky, President and Chief Executive OfficerJanuary 14, 2021 Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This presentation and the accompanying oral remarks include forward-looking statements regarding, without limitation, the Company’s strategic position, its proje |
|
| January 4, 2021 |
Molina Healthcare Announces the Closing of its Acquisition of Magellan Complete Care Exhibit 99.1 Molina Healthcare Announces the Closing of its Acquisition of Magellan Complete Care LONG BEACH, Calif.-(BUSINESS WIRE)-January 4, 2021-Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) today announced that its acquisition of the Magellan Complete Care (“MCC”) line of business of Magellan Health, Inc. closed on December 31, 2020. As of November 30, 2020, MCC served approximately 200,000 |
|
| January 4, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits - MOLINA HEALTHCARE, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2021 (January 4, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| November 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2020 (November 17, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco |
|
| November 19, 2020 |
Molina Healthcare Announces CFO Transition with Retirement of Tom Tran in 2021 Exhibit 99.1 Molina Healthcare Announces CFO Transition with Retirement of Tom Tran in 2021 Mark Keim to Assume CFO Role LONG BEACH, Calif.-(BUSINESS WIRE)-November 19, 2020-Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) today announced that Tom Tran has stated his intention to retire from Molina. Mark Keim, Molina?s executive vice president of strategic planning, corporate development and transfo |
|
| November 17, 2020 |
Molina Healthcare Announces Closing of Offering of $650 Million of 3.875% Senior Notes Due 2030 Exhibit 99.1 Molina Healthcare Announces Closing of Offering of $650 Million of 3.875% Senior Notes Due 2030 LONG BEACH, Calif.-(BUSINESS WIRE)-November 17, 2020-Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the closing of its previously announced offering of $650 million aggregate principal amount of 3.875% Senior Notes due 2030 (the “Notes”) sold in a private offering to in |
|
| November 17, 2020 |
Exhibit 4.1 MOLINA HEALTHCARE, INC. $650,000,000 3.875% Senior Notes due 2030 INDENTURE Dated as of November 17, 2020 U.S. BANK NATIONAL ASSOCIATION as Trustee TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions. 1 Section 1.02 Other Definitions. 13 Section 1.03 Incorporation by Reference of Trust Indenture Act. 13 Section 1.04 Rules of Constructi |
|
| November 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2020 (November 17, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco |
|
| November 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2020 (November 2, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorp |
|
| November 3, 2020 |
Exhibit 1.1 PURCHASE AGREEMENT November 2, 2020 BofA Securities, Inc. As Representative of the Initial Purchasers c/o BofA Securities, Inc. One Bryant Park New York, New York 10036 Ladies and Gentlemen: Molina Healthcare, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to BofA Securities, Inc. (“BofAS”) and the other several Initial Purchasers named in Schedule A attached |
|
| November 3, 2020 |
Molina Healthcare Announces Pricing of $650 Million of Senior Notes Due 2030 Exhibit 99.1 Molina Healthcare Announces Pricing of $650 Million of Senior Notes Due 2030 LONG BEACH, Calif.-(BUSINESS WIRE)-November 2, 2020-Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it priced $650 million aggregate principal amount of its senior notes due 2030 (the “Notes”) to be sold in a private offering to individuals reasonably believed to be “qualified institu |
|
| November 2, 2020 |
Molina Healthcare Announces Proposed Offering of $650 Million of Senior Notes Due 2030 Exhibit 99.1 Molina Healthcare Announces Proposed Offering of $650 Million of Senior Notes Due 2030 LONG BEACH, Calif.-(BUSINESS WIRE)-November 2, 2020-Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it intends to privately offer, subject to market and other conditions, $650 million aggregate principal amount of senior notes due 2030 (the “Notes”). The Company will make th |
|
| November 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2020 (November 2, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorp |
|
| October 29, 2020 |
EXECUTION COPY ASSET PURCHASE AGREEMENT by and between AFFINITY HEALTH PLAN, INC. and MOLINA HEALTHCARE, INC. Dated as of September 28, 2020 43927.00005 Table of Contents Page ARTICLE I DEFINITIONS 1 ARTICLE II PURCHASE AND SALE 18 Section 2.01 Purchase and Sale of Assets 18 Section 2.02 Excluded Assets 20 Section 2.03 Assumed Liabilities 21 Section 2.04 Excluded Liabilities 21 Section 2.05 Purcha |
|
| October 29, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe |
|
| October 28, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2020 (October 28, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor |
|
| October 28, 2020 |
News Release Investor Contact: Julie Trudell, [email protected], 562-912-6720 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2020 Financial Results Reports Third Quarter GAAP EPS of $3.10 and Adjusted EPS of $3.36 Long Beach, Calif., October 28, 2020 – Molina Healthcare, Inc. (NYSE: MOH) today reported n |
|
| September 29, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - MOLINA HEALTHCARE, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2020 (September 29, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of in |
|
| September 29, 2020 |
Molina Healthcare to Acquire Affinity Health Plan Exhibit 99.1 Molina Healthcare to Acquire Affinity Health Plan Represents Excellent Fit with Existing Portfolio Immediately Accretive to Adjusted Earnings Per Share Maintains Stability for New York State Partner LONG BEACH, Calif.-(BUSINESS WIRE)-September 29, 2020-Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) announced today that it has entered into a definitive agreement to acquire substantiall |
|
| September 29, 2020 |
Exhibit 99.2 |
|
| September 29, 2020 |
Entry into a Material Definitive Agreement - MOLINA HEALTHCARE, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2020 (September 28, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of in |
|
| July 31, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00 |
|
| July 30, 2020 |
News Release Investor Contact: Julie Trudell, [email protected], 562-912-6720 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2020 Financial Results Introduces Full Year 2021 Premium Revenue Growth Expectation of 20 Percent Long Beach, Calif., July 30, 2020 – Molina Healthcare, Inc. (NYSE: MOH) today rep |
|
| July 30, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 (July 30, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| July 30, 2020 |
News Release Investor Contact: Julie Trudell, [email protected], 562-912-6720 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2020 Financial Results Introduces Full Year 2021 Premium Revenue Growth Expectation of 20 Percent Long Beach, Calif., July 30, 2020 – Molina Healthcare, Inc. (NYSE: MOH) today rep |
|
| July 30, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 (July 30, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| June 8, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2020 (June 8, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| June 8, 2020 |
Exhibit 10.1 DEAL CUSIP: 60855QAK8 REVOLVER CUSIP: 60822QAL6 CREDIT AGREEMENT dated as of June 8, 2020 among MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank SUNTRUST ROBINSON HUMPHREY, INC. BARCLAYS BANK PLC BOFA SECURITIES, INC. DEUTSCHE BANK SECURITIES INC. MUFG UNION BANK, N.A.. and WEL |
|
| June 2, 2020 |
Exhibit 4.1 Execution Version MOLINA HEALTHCARE, INC. $800,000,000 4.375% Senior Notes due 2028 INDENTURE Dated as of June 2, 2020 U.S. BANK NATIONAL ASSOCIATION as Trustee TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions. 1 Section 1.02 Other Definitions. 13 Section 1.03 Incorporation by Reference of Trust Indenture Act. 13 Section 1.04 Rules |
|
| June 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2020 (June 2, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| June 2, 2020 |
Molina Healthcare Announces Closing of Offering of $800 Million of 4.375% Senior Notes Due 2028 Exhibit 99.1 Molina Healthcare Announces Closing of Offering of $800 Million of 4.375% Senior Notes Due 2028 LONG BEACH, Calif.-(BUSINESS WIRE)-June 2, 2020-Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the closing of its previously announced offering of $800 million aggregate principal amount of 4.375% Senior Notes due 2028 (the “Notes”) sold in a private offering to “qualif |
|
| June 1, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2020 (May 29, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| June 1, 2020 |
Molina Healthcare Wins Kentucky Medicaid Contract Exhibit 99.1 Molina Healthcare Wins Kentucky Medicaid Contract LONG BEACH, Calif.-(BUSINESS WIRE)-May 29, 2020-Molina Healthcare, Inc. (NYSE: MOH) today announced that its Kentucky health plan subsidiary has been selected as an awardee pursuant to the statewide Medicaid managed care RFP issued on January 10, 2020 by the Kentucky Cabinet for Health and Family Services (CHFS), Department for Medicai |
|
| May 29, 2020 |
Exhibit 1.1 PURCHASE AGREEMENT May 28, 2020 SUNTRUST ROBINSON HUMPHREY, INC. As Representative of the Initial Purchasers 3333 Peachtree Road NE Atlanta, GA 30326 Ladies and Gentlemen: Molina Healthcare, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to SunTrust Robinson Humphrey, Inc. (“SunTrust”) and the other several Initial Purchasers named in Schedule A attached heret |
|
| May 29, 2020 |
Molina Healthcare Announces Pricing of Offering of $800 Million of Senior Notes Due 2028 Exhibit 99.1 Molina Healthcare Announces Pricing of Offering of $800 Million of Senior Notes Due 2028 LONG BEACH, Calif.-(BUSINESS WIRE)-May 28, 2020-Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it priced $800 million aggregate principal amount of its senior notes due 2028 (the “Notes”) to be sold in a private offering to “qualified institutional buyers” pursuant to Rul |
|
| May 29, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2020 (May 28, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| May 28, 2020 |
Molina Healthcare Announces Proposed Offering of $800 Million of Senior Notes Due 2028 Exhibit 99.1 Molina Healthcare Announces Proposed Offering of $800 Million of Senior Notes Due 2028 LONG BEACH, Calif.-(BUSINESS WIRE)-May 28, 2020-Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it intends to privately offer, subject to market and other conditions, $800 million aggregate principal amount of senior notes due 2028 (the “Notes”). The Company will make the of |
|
| May 28, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2020 (May 27, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) |
|
| May 15, 2020 |
Exhibit 10.1 SEVENTH AMENDMENT TO CREDIT AGREEMENT THIS SEVENTH AMENDMENT TO CREDIT AGREEMENT, dated as of May 14, 2020 (this “Amendment”), is entered into among Molina Healthcare, Inc., a Delaware corporation (the “Borrower”), the Guarantors party hereto, the Lenders party hereto, and Truist Bank (successor by merger to SunTrust Bank), in its capacity as Administrative Agent (the “Administrative |
|
| May 15, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2020 (May 14, 2020) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) |
